Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
ClearBridge BioMedics
ClearBridge BioMedics
Activities:
Manufacturing
Research & Development
Analysis
X
LinkedIn
Trending Articles
OINDPs: Nosey about recent developments?
OINDPs are a user friendly and efficacious alternative to injectables in several disease areas
Transforming healthcare with patient centricity
In this opinion article, John Kytariolos, Head of Clinical and Scientific Affairs at Adragos Pharma, discusses patient-centric dosage forms, their properties and the impact...
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Compact process thermostat for efficient temperature control in the laboratory
The temperature control system is designed for the accurate temperature control of small research reactors between -40 to +200 °C
AviadoBio expands presence at Canary Wharf
The company has acquired 11,000 sqft of laboratory and office space in Canary Wharf to accommodate the growing team
Upcoming event
Making Pharmaceuticals
23–24 April 2024 | Exhibition | Coventry, UK
See all
Related Content
Research & Development
Supporting circulating tumour cell (CTC) research
Clearbridge BioMedics and Leica Biosystems will co-market each other’s products to support circulating tumour cell (CTC) research
Regulatory
Clearbridge BioMedics joins CANCER-ID consortium
Clearbridge BioMedics has joined CANCER-ID, a public-private international consortium, which aims to establish standard protocols for and clinical validation of blood-based biomarkers
Manufacturing
Dolomite and ClearBridge develop ClearCell instrument
Detects circulating tumour cells and paves the way for personalised cancer treatment
Subscribe now